Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991 Dec;8(12):1533-8.
doi: 10.1023/a:1015854718903.

Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach

Affiliations
Comparative Study

Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach

A H Kahns et al. Pharm Res. 1991 Dec.

Abstract

Various derivatives of the C-terminal amide group in N-protected amino acid and peptide amides were synthesized to assess their suitability as prodrug forms with the aim of protecting the amide or peptide bond against cleavage by alpha-chymotrypsin. Whereas N-acetylation, N-hydroxymethylation, and N-phthalidylation did not afford any protection but, in fact, accelerated the terminal amide bond cleavage, condensation with glyoxylic acid to produce peptidyl-alpha-hydroxyglycine derivatives and, to a minor extent, N-aminomethylation were found to improve the stability of the parent amides. Besides protecting the terminal, derivatized amide moiety toward cleavage by alpha-chymotrypsin, alpha-hydroxyglycine derivatization resulted in a significant protection, by a factor ranging from 5 to 75, of the internal peptide bond in various N-protected dipeptide amides. These derivatives are readily bioreversible, the conversion to the parent peptide or amino acid amide taking place either by spontaneous hydrolysis at physiological pH, as demonstrated for the N-Mannich bases, or by catalysis by plasma, as for peptidyl-alpha-hydroxyglycine derivatives.

PubMed Disclaimer

References

    1. Methods Enzymol. 1985;112:347-59 - PubMed
    1. J Pharm Sci. 1980 Jan;69(1):44-6 - PubMed
    1. J Med Chem. 1988 Dec;31(12):2277-88 - PubMed
    1. Pharm Res. 1991 Mar;8(3):313-22 - PubMed
    1. Arch Biochem Biophys. 1977 Jan 15;178(1):188-94 - PubMed

Publication types

LinkOut - more resources